The current mindset that all data, automated or otherwise, is proprietary and its exchange could prove competitively disadvantageous is a hindrance. Apparently, some data is proprietary but more data should be shared to mitigate the complexity and rising costs of clinical trials, prompting sponsors to run more efficient clinical trials with faster enrollments.

Leave a Reply

Your email address will not be published. Required fields are marked *